As of 2025-07-14, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (35.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -193.5%.
The range of the Relative Valuation is (29.30) - (39.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.2x | 20.2x |
| Forward P/E multiples | 17.8x - 28.8x | 23.3x |
| Fair Price | (29.30) - (39.69) | (35.73) |
| Upside | -176.7% - -203.8% | -193.5% |
| Date | P/E |